» Articles » PMID: 34516352

Identification of Downstream Targets and Signaling Pathways of Long Non-coding RNA NR_002794 in Human Trophoblast Cells

Overview
Journal Bioengineered
Date 2021 Sep 13
PMID 34516352
Authors
Affiliations
Soon will be listed here.
Abstract

Preeclampsia (PE) is a huge threat to pregnant women. Our previous study demonstrated that long non-coding RNA (lncRNA) NR_002794 was highly expressed in placentas of PE patients and could regulate the phenotypes of trophoblast cells. However, the downstream regulatory mechanisms of NR_002794 remain unknown. In this text, some potential downstream targets or signaling pathways of NR_002794 were identified through RNA sequencing (RNA-seq) and bioinformatics analysis in SWAN71 trophoblast cells. Western blot assay demonstrated that NR_002794 inactivated protein kinase B (AKT) and extracellular signal-regulated kinase 1/2 (ERK1/2) pathways and activated cell apoptotic signaling in SWAN71 cells. Both RNA-seq and reverse transcription-quantitative PCR (RT-qPCR) outcomes showed that NR_002794 up-regulation could notably inhibit the expression of C-C motif chemokine ligand 4 like 2 (CCL4L2), interleukin 15 receptor subunit alpha (IL15RA), interleukin 32 (IL32), and tyrosine kinase with immunoglobulin-like and EGF-like domains 1 (TIE1), while NR_002794 knockdown induced these gene expressions in SWAN71 cells. CCK-8, BrdU, Transwell, wound healing, and flow cytometry analyses showed that NR_002794 inhibited cell proliferation and migration and induced cell apoptosis through down-regulating TIE1 in SWAN71 cells. In conclusion, lncRNA NR_002794 could exert its functions by regulating AKT and ERK1/2 pathways and TIE1 expression in human trophoblast cells.

References
1.
Li J, Hu L, Zhou T, Gong X, Jiang R, Li H . Taxifolin inhibits breast cancer cells proliferation, migration and invasion by promoting mesenchymal to epithelial transition via β-catenin signaling. Life Sci. 2019; 232:116617. DOI: 10.1016/j.lfs.2019.116617. View

2.
Yang P, Chen N, Jia J, Gao X, Li S, Cai J . Tie-1: A potential target for anti-angiogenesis therapy. J Huazhong Univ Sci Technolog Med Sci. 2015; 35(5):615-622. DOI: 10.1007/s11596-015-1479-1. View

3.
Hou W, Ye C, Chen M, Li W, Gao X, He R . Bergenin Activates SIRT1 as a Novel Therapeutic Agent for Osteogenesis of Bone Mesenchymal Stem Cells. Front Pharmacol. 2019; 10:618. PMC: 6586741. DOI: 10.3389/fphar.2019.00618. View

4.
Yang X, Meng T . Long Noncoding RNA in Preeclampsia: Transcriptional Noise or Innovative Indicators?. Biomed Res Int. 2019; 2019:5437621. PMC: 6487157. DOI: 10.1155/2019/5437621. View

5.
Dhariwal N, Lynde G . Update in the Management of Patients with Preeclampsia. Anesthesiol Clin. 2017; 35(1):95-106. DOI: 10.1016/j.anclin.2016.09.009. View